First 20 Pharma/ Biotech delegates to register pay £399+VAT
Conference Only pass.

Confirmed 2014 speakers

 Rachel Mager
Rachel Mager
Global Head of Biobanking
Astra Zeneca
 Andy Zaayenga
Andy Zaayenga
president
ISBER
 James Brennan
James Brennan
IT maanger
Uk Biobank
 Claire Troakes
Claire Troakes
coordinator, MRC London Neurodegenerative Diseases Brain Bank
Kings College London
 Dr Kirstin Goldring
Dr Kirstin Goldring
UCL Biobank and NIHR BioResource Coordinator
UCL
 Evert-Ben van Veen
Evert-Ben van Veen
Medical Lawyer
MedLawconsult
 Pedro Rondot Radio
Pedro Rondot Radio
Executive Director: Public Oncologic Serum Biobank
Universidad de Buenos Aires
 Gisli Jenkins
Gisli Jenkins
Clinical Associate Professor & Reader in Pulmonary Biology,, Faculty of Medicine & Health Sciences
University of Nottingham
 Kathi Shea
Kathi Shea
Vice President BioServices Operations
Vice President Bioservices Precision Bioservices (President Elect ISBER) )
 Berthold Huppertz
Berthold Huppertz
Director and CEO
Medical University of Graz
 Timo Minssen
Timo Minssen
Associate Professor and part of Global Genes, Local Concerns Project
University of Copenhagen
 Steve Rees
Steve Rees
Vice President, Screening Sciences and Sample Management
Astrazeneca R&D
 Rose Gonzales
Rose Gonzales
Director of Compound Management
Pfizer
 Troels Marstrand
Troels Marstrand
Computional Biologist
Leo Pharma
 Daniel Baeschlin
Daniel Baeschlin
Director of Compound Management
Novartis

Biobanking will grow by 30% by 2020, will yours grow with it?

With Biobanking becoming increasingly important with the rise of biologic and personalised medicine making sure you can get the most out of your samples is key.

The conference will allow you to understand cross border regulatory requirements, the impact of the pending EU regulations, consent, efficient storage and tracking strategies to ensure quality. This will all allow you to move forward with your research and improve your drug discovery process.

We bring together leaders from industry, academia and institutions from across the globe facilitating learning and development to maximise your research opportunities.

Representatives from the UK Biobank, ISBER, Astrazeneca, and Leo pharma and many others highlight the newest and most innovative advances in the industry.

Overcome the challenges stopping you from having the most efficient biobank, enabling you to:

  • Overcome data management challenges and how best to build an in house data system
  • Maximise sample utilisation and quality
  • Understand ethical and legal guidelines
  • Understand worldwide requirements and standardisation within biobanking
  • Collaborate and network between different institutes
  • Understand the technical advances between sample collection, assaying, storage and retrieval

Sponsors & Exhibitors
Media Partners

Download the Brochure